<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5)*
LYNX THERAPEUTICS, INC.
- -----------------------------------------------------------------------------
(NAME OF ISSUER)
COMMON STOCK, $0.001 PAR VALUE
- -----------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
COMMON STOCK: 551812100
- -----------------------------------------------------------------------------
(CUSIP NUMBER)
- --------------
*THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING
PERSON'S INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF
SECURITIES, AND FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH
WOULD ALTER DISCLOSURES PROVIDED IN A PRIOR COVER PAGE.
THE INFORMATION REQUIRED IN THE REMAINDER OF THIS COVER PAGE SHALL NOT
BE DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES
EXCHANGE ACT OF 1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT
SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT
(HOWEVER, SEE THE NOTES).
<PAGE>
- ----------------------- ----------------
CUSIP No. 551812100 13G Page 2 of 5
- ----------------------- ----------------
- -------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Chiron Corporation, I.R.S. Identification No. 94-2754624
- -------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
5. SOLE VOTING POWER
119,300 shares of Common Stock
-----------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY EACH -----------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON WITH
119,300 shares of Common Stock
-----------------------------------------------------------
8. SHARED DISPOSITIVE POWER
-0-
- -------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
119,300 shares of Common Stock
- -------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
Common Stock: 2%
- -------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ----------------
CUSIP No. 551812100 13G Page 3 of 5
- ----------------------- ----------------
ITEM 1(a). NAME OF ISSUER:
Lynx Therapeutics, Inc.
- -------------------------------------------------------------------------------
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
3832 Bay Center Place, Hayward, CA 94545
- -------------------------------------------------------------------------------
ITEM 2(a). NAME OF PERSON FILING:
Chiron Corporation
- -------------------------------------------------------------------------------
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
4560 Horton Street, Emeryville, CA 94608
- -------------------------------------------------------------------------------
ITEM 2(c). CITIZENSHIP:
Delaware
- -------------------------------------------------------------------------------
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, $0.001 Par Value
- -------------------------------------------------------------------------------
ITEM 2(e). CUSIP NUMBER:
Common Stock: 551812100
- -------------------------------------------------------------------------------
ITEM 3.
Not applicable
- -------------------------------------------------------------------------------
<PAGE>
- ----------------------- ----------------
CUSIP No. 551812100 13G Page 4 of 5
- ----------------------- ----------------
ITEM 4. OWNERSHIP.
If the percent of the class owned as of December 31 of the year covered by
the statement, or as of the last day of any month described in Rule 13d-1 (b)
(2), if applicable, exceeds five percent, provide the following information as
of that date and identify those shares which there is a right to acquire.
(a) Amount Beneficially Owned:
Not applicable
(b) Percent of Class:
Not applicable
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
Not applicable
(ii) Shared power to vote or to direct the vote:
Not applicable
(iii) Sole power to dispose or to direct the disposition of:
Not applicable
(iv) Shared power to dispose or to direct the disposition of:
Not applicable
- -------------------------------------------------------------------------------
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [X].
- -------------------------------------------------------------------------------
<PAGE>
- ----------------------- ----------------
CUSIP No. 551812100 13G Page 5 of 5
- ----------------------- ----------------
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable
- -------------------------------------------------------------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable
- -------------------------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable
- -------------------------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable
- -------------------------------------------------------------------------------
ITEM 10. CERTIFICATION.
Not applicable
- -------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
CHIRON CORPORATION
Date: February 12, 1998 By: /s/William G. Green
--------------------------------------
Signature
William G. Green, Senior Vice President,
Secretary and General Counsel
-----------------------------------------
Name/Title
PAGE 5 OF 5 PAGES
